Cytokinetics Stock Technical Analysis
| CYTK Stock | USD 63.52 1.21 1.87% |
As of the 5th of February, Cytokinetics shows the Risk Adjusted Performance of 0.0252, downside deviation of 2.3, and Mean Deviation of 2.12. Cytokinetics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cytokinetics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cytokinetics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CytokineticsCytokinetics | Build AI portfolio with Cytokinetics Stock |
Cytokinetics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 89.94 | Strong Buy | 21 | Odds |
Most Cytokinetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cytokinetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cytokinetics, talking to its executives and customers, or listening to Cytokinetics conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. Projected growth potential of Cytokinetics fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytokinetics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (6.30) | Revenue Per Share | Quarterly Revenue Growth 3.181 | Return On Assets | Return On Equity |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cytokinetics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytokinetics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cytokinetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cytokinetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cytokinetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cytokinetics.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Cytokinetics on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Cytokinetics or generate 0.0% return on investment in Cytokinetics over 90 days. Cytokinetics is related to or competes with Nuvalent, Abivax SA, Axsome Therapeutics, Rhythm Pharmaceuticals, Halozyme Therapeutics, Jazz Pharmaceuticals, and Corcept Therapeutics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializ... More
Cytokinetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cytokinetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cytokinetics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.3 | |||
| Information Ratio | (0.0006) | |||
| Maximum Drawdown | 10.86 | |||
| Value At Risk | (3.67) | |||
| Potential Upside | 4.25 |
Cytokinetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cytokinetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cytokinetics' standard deviation. In reality, there are many statistical measures that can use Cytokinetics historical prices to predict the future Cytokinetics' volatility.| Risk Adjusted Performance | 0.0252 | |||
| Jensen Alpha | 0.0123 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | (0.0007) | |||
| Treynor Ratio | 0.071 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cytokinetics February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0252 | |||
| Market Risk Adjusted Performance | 0.081 | |||
| Mean Deviation | 2.12 | |||
| Semi Deviation | 2.25 | |||
| Downside Deviation | 2.3 | |||
| Coefficient Of Variation | 4081.77 | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.61 | |||
| Information Ratio | (0.0006) | |||
| Jensen Alpha | 0.0123 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | (0.0007) | |||
| Treynor Ratio | 0.071 | |||
| Maximum Drawdown | 10.86 | |||
| Value At Risk | (3.67) | |||
| Potential Upside | 4.25 | |||
| Downside Variance | 5.28 | |||
| Semi Variance | 5.07 | |||
| Expected Short fall | (2.47) | |||
| Skewness | 0.312 | |||
| Kurtosis | (0.28) |
Cytokinetics Backtested Returns
As of now, Cytokinetics Stock is very steady. Cytokinetics secures Sharpe Ratio (or Efficiency) of 0.0478, which signifies that the company had a 0.0478 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Cytokinetics, which you can use to evaluate the volatility of the firm. Please confirm Cytokinetics' Mean Deviation of 2.12, downside deviation of 2.3, and Risk Adjusted Performance of 0.0252 to double-check if the risk estimate we provide is consistent with the expected return of 0.12%. Cytokinetics has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.75, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cytokinetics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cytokinetics is expected to be smaller as well. Cytokinetics right now shows a risk of 2.57%. Please confirm Cytokinetics value at risk, as well as the relationship between the skewness and day median price , to decide if Cytokinetics will be following its price patterns.
Auto-correlation | -0.36 |
Poor reverse predictability
Cytokinetics has poor reverse predictability. Overlapping area represents the amount of predictability between Cytokinetics time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cytokinetics price movement. The serial correlation of -0.36 indicates that just about 36.0% of current Cytokinetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.36 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 1.45 |
Cytokinetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cytokinetics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cytokinetics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Cytokinetics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cytokinetics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cytokinetics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cytokinetics price pattern first instead of the macroeconomic environment surrounding Cytokinetics. By analyzing Cytokinetics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cytokinetics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cytokinetics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 8.43 | 7.82 | 8.99 | 7.14 | Revenue Per Share | 0.078 | 0.16 | 0.19 | 0.18 |
Cytokinetics February 5, 2026 Technical Indicators
Most technical analysis of Cytokinetics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cytokinetics from various momentum indicators to cycle indicators. When you analyze Cytokinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0252 | |||
| Market Risk Adjusted Performance | 0.081 | |||
| Mean Deviation | 2.12 | |||
| Semi Deviation | 2.25 | |||
| Downside Deviation | 2.3 | |||
| Coefficient Of Variation | 4081.77 | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.61 | |||
| Information Ratio | (0.0006) | |||
| Jensen Alpha | 0.0123 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | (0.0007) | |||
| Treynor Ratio | 0.071 | |||
| Maximum Drawdown | 10.86 | |||
| Value At Risk | (3.67) | |||
| Potential Upside | 4.25 | |||
| Downside Variance | 5.28 | |||
| Semi Variance | 5.07 | |||
| Expected Short fall | (2.47) | |||
| Skewness | 0.312 | |||
| Kurtosis | (0.28) |
Cytokinetics February 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cytokinetics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 64,475 | ||
| Daily Balance Of Power | (0.42) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 63.80 | ||
| Day Typical Price | 63.71 | ||
| Price Action Indicator | (0.88) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytokinetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. Projected growth potential of Cytokinetics fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytokinetics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (6.30) | Revenue Per Share | Quarterly Revenue Growth 3.181 | Return On Assets | Return On Equity |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cytokinetics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytokinetics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cytokinetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.